New White Paper Explores Nanoneedle Technology for Enhanced AAV Manufacturing

February 12, 2025 - 14:08

Nanomosaic has unveiled a scientific white paper that delves into the potential of nanoneedle technology to enhance the manufacturing process and product quality of adeno-associated viruses (AAV). This collaborative study, conducted in partnership with BMS, aims to address the challenges faced in AAV production, which is crucial for gene therapy applications.

The white paper highlights innovative methodologies that leverage nanoneedle technology to improve the efficiency and reliability of AAV manufacturing. By utilizing advanced techniques, the research suggests significant improvements in the yield and purity of AAV products, which are essential for successful therapeutic outcomes.

This publication marks a significant step forward in the field of gene therapy, as it provides insights into how nanotechnology can be harnessed to optimize biomanufacturing processes. The findings are expected to pave the way for more effective and scalable production of AAVs, ultimately benefiting patients who rely on these therapies for various genetic disorders.